Abstract
In accordance with the wishes of the Editor, a chapter on the chemistry of antihypertensive agents precedes the pharmacological chapters. If the author has not succeeded in giving all chemical structures for antihypertensive agents mentioned in subsequent contributions, his only consolation for this failure is the fact that this “Handbuch” is concerned with activity of drugs and not with their chemistry. It is not the chemistry but the biological activity which counts in this field of research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aldrich, P.E., Diassi, P.A., Dickel, D.F., Dylion, C.M., Hance, P.D., Huebner, C.F., Korzun, B., Kuehne, M.E., Liu, L.H., McPhillamy, H.B., Robb, E.W., Roychaudhuri, D.K., Schlittler, E., St. Andre, Van Tamelen, Weisenborn, F.L., Wenkert, E., Wintersteiner, O.: The stereochemistry of reserpine, deserpidine and related alkaloids. J. Amer. chem. Soc. 81, 2481–2494 (1959).
Alles, G.A.: Comparative physiological action of some derivates of guanidine. J. Pharmacol. exp. Ther. 28, 251–276 (1926).
Anderson, P. L., Houlihan, W.J., Manning, R.E.: Antihypertensive hydrazinopyridazines. Chem. Abstr. 73, 120, 655w (1971).
Appel, W.: α-Isopropyl-α[(N-methyl-N-homoveratryl)γ-aminopropyl]-3, 4-dimethoxyphenyl-acetonitril, sein Nachweis im biologischen Material und sein Verhalten im Blut. Arzneimittel-Forsch. 12, 562–566 (1962).
Arcari, G., Bernardi, L., Bosisio, G., Coda, S., Fregnan, G.B., Glässer, A.H.: 10-Methoxy-ergoline derivatives as α-adrenergic blocking agents. Experientia (Basel) 28, 819–820 (1972).
Arcari, G., Dorigotti, L., Fregnan, G.B., Glässer, A.H.: Vasodilating and α-receptor blocking activity of a new ergoline derivative. Brit. J. Pharmacol. 34, 700P (1968).
Archer, S., Wylie, D.W., Harris, L.S., Lewis, T.R., Schulenberg, J. W., Bell, M.R., Kullnig, R.K., Arnold, A.: l-(Indolalkyl)-4-arylpiperazines a new class of tranquilizers. J. Amer. chem. Soc. 84, 1306–1307 (1962).
Archibald, J.L., Alps, B.J., J.F., Jackson, J. L.: Synthesis and hypotensive activity of benzamidopiperidyl ethylindole. J. med. Chem. 14, 1054–1059 (1971).
Arya, V.P., Grewal, R.S., David, J., Kaul, C.L.: l-(5-Methyl-l-phenyl-4-pyrazolyl)-3-(4-((o-tolyl)piperazinyl)-l-propanone, a new synthetic antihypertensive agent. Experientia (Basel) 23, 514–515 (1967).
Augstein, J., Green, S.M., Katritzky, Monro, A.M.: The synthesis, proof of structure, and biological activity of some monosubstituted aminoguanidines. J. med. Chem. 8, 395–397 (1965a).
Augstein, J., Green, S.M., Monro, A.M., Potter, G.W.H., Worthing, C.R., Wrigley, T.I.: Adrenergic neurone blocking agents derived from 1, 4 benzodioxan. J. Med. Chem. 8, 446–456 (1965b); see also Monro, A.M.: A new synthesis of guanidines. Chem. Ind. (Lond.) 1964, 1806.
Augstein, Monro, A.M., Potter, G.W.H., Scholfield, P.: Adrenergic neurone blocking agents III: Heterocyclic analogs of guanoxan. J. med. Chem. 11, 844–848 (1968).
Ayers, J.B., Waggoner, W. H.: Synthesis and properties of a series of pentacyanoferrates. J. inorg. nuclear. Chem. 31, 2045–2051 (1969); Chem. Abstr. 71, 66.787j (1969).
Ayman, D.: Potassium thiocyanate in the treatment of essential hypertension (its practicability). J. Amer. med. Ass. 96, 1852–1857 (1931).
Ayman, D.: Bismuth subnitrate in the treatment of essential hypertension. J. Amer. med. Ass. 98, 545–548 (1932).
Baines, M.W., Cobb, D.B., Eden, R.J., Fielden, R., Gardner, J.N., Roe, A.M., Tertiuk, W., Willey, G.L.: The synthesis and pharmacology of some stubstituted 1, 3 benzdioxoles and 1, 4-benzdioxans. J. med. Chem. 8, 81–90 (1965).
Baker, P.D.: Sth. Med. Surg. 15, 579 (1859).
Barger, G.: Ergot and Ergotism. London-Edinburgh: Gurney and Jackson 1931.
Barger, G., Carr, F.H.: The alkaloids of ergot. J. chem. Soc. 91, 337–353 (1907).
Barker, M.: The blood cyanates in the treatment of hypertension. J. Amer. med. Ass. 106, 762–767 (1936).
Barlow, R.B., Ing, H.R.: Curare like action of polymethylene bis-quaternary ammonium salts. Nature (Lond.) 161, 718 (1948).
Barlow, R.B., Ing, H.R.: Curare-like action of polymethylene bis-quaternary ammonium salts. Brit. J. Pharmacol. 3, 298–304 (1948).
Barrett, W.E., Mull, R.P., Plummer, A.J.: Hypotensive activity of cis-cinnamyl guanidine sulfate. Experientia (Basel) 21, 506 (1965).
Barron, D.I., Bavin, P.M.G., Durant, G.J., Natoff, I.L., Spickett, R.G., Vallance, D.K.: Potential antihypertensive agents: Some guanidine derivatives. J. med. Chem. 6, 705–711 (1963).
Barron, D.I., Natoff, I.L., Vallance, D.K.: Pharmacology of N-[2-(2, 6-xylyloxy)ethyl]-guanidine sulfate: An adrenergic neurone blocking agent. Brit. J. Pharmacol. 25, 534–544 (1965).
Barton, D.H.R., Jeger, O., Prelog, V., Woodward, R.B.: The constitution of cevine and some related alkaloids. Experientia (Basel) 10, 81–90 (1954).
Baum, T., Shropshire, A.T., Rowles, G., Van Pelt, R., Fernandez, S.P., Eckfeld, D.K., Gluckman, M.I.: General pharmacologic actions of the antihypertensive agent 2, 6-dichlorobenzylidene aminoguanidine acetate, WY 8678. J. Pharmacol. exp. Ther. 171, 276–287 (1970).
Begeka, A.D., Groisman, S.D.: Effect of different doses of sympatholytic isobarin on the evacuative function of the stomach in dogs: Fiziol. Zh. (Kiev) 21, 649–653 (1975). (Chem. Abstr. 83, 188405b (1975).
Bell, M.R., Hoppe, J.O., Lape, H.E., Wood, D., Arnold, A., Selberis, W.H.: Antihypertensive activity of 7-azaindole-3-acetamidoxime and indole-1-acetamidoxime. Experientia (Basel) 23, 298–299 (1967).
Bellasio, E., Carpi, C., Maffii, G., Testa, E.: 3-Hydrazino-6-aminopyridazines. Chem. Abstr. 75, 151.820s (1971).
Bellasio, E., Parravicini, F., Testa, E.: 3-Hydrazinopyridazines containing basic groups in 6-position and possessing hypotensive activity. Farmaco, Ed. sci. 24, 919–929 (1969); Chem. Abstr. 72, 121.471z (1970).
Bernardi, L.: Recent developments in the chemistry of ergot alkaloids. Chimica Industria 51, 563–569 (1969).
Berthaux, P., Neuman, M.: Etude pharmacologique et clinique d’un nouvel hypotenseur réserpinique: DL 152 ou Biétaserpine. Arzneimittel-Forsch. 14, 1040–1045 (1964).
Bhatia, B.B.: On the use of Rauwolfia serpentina in high blood pressure. J. Indian med. Ass. 11, 262–265 (1942).
Bierbaum, B.A., Traverso, J. J., Whitehead, C.W.: Hypotensive 1, 2, 4-benzothiadiazines. J. med. Chem. 6, 272–275 (1963).
Black, M.M., Zweifach, B.W., Speer, F.D.: Comparison of hypotensive action of sodium azide in normotensive and hypertensive patients. Proc. Soc. exp. Biol. (N. Y.) 85, 11–16 (1954).
Bloomfield, D.K., Cangiano, J.L.: Guanadrel and guanethidine in hypertension. Clin. Pharmacol. Ther. 11, 200–204 (1970).
Boehringer-Ingelheim: U.S. Pat. 3.190.802 (German prior. 10/9/1961). Chem. Abstr. 64, 2096 (1966).
Botton, I., Kinnard, W.J., Buckley, J.P.: Hypotensive activity of β-heptyleneiminoethyl-amino guanidine sulfate. J. Pharmacol. exp. Ther. 152, 243–250 (1966).
Boura, A. L. A., Copp, F. C., Green, A.F.: New adrenergic compounds. Nature (Lond.) 184, BA 70, (1959).
Boura, A.L.A., Copp, F.C., Green, A.F.: Amidines as adrenergic neurone blocking agents. Nature (Lond.) 195, 1213–1214 (1962).
Boura, A.L.A., Copp, F.C., Green, A.F., Hodson, H.F., Ruffel, G.K., Sim, M.F., Walton, E.: Adrenergic neurone blocking agents related to choline 2, 6-xylyl ether bromide (T.M.10), bretylium, and guanethidine. Nature (Lond.) 191, 1312–1313 (1961).
Boura, A.L.A., Green, A.F.: The actions of bretylium: Adrenergic neurone blocking and other effects. Brit. J. Pharmacol. 14, 536–548 (1959).
Bovet, D., Depierre, F., Be Lestrange, Y.: Propriétés curarisantes des éthers phénoliques à fonctions ammonium quaternaires. C. R. Acad. Sci. (Paris) 225, 74–76 (1947).
Boyajy, L.D., Manning, R., McIntosh, R.E., Schäfer, F., Herzig, M., Schaaf, J., Trapold, J.H.: Cardiovascular effects of 2-(2, 6-dichlorophenyl)-5, 6-dihydroimidazo-(2, l-b-thiazole)-hydrobromide. 166th ACS Meeting, Chicago, August 1973, Abstracts Medi-22.
Bream, J.B., Picard, C.W., White, T.G., Lauener, H.: Aralkylaminoguanidines and related compounds. J. med. Chem. 13, 1051–1057 (1970).
Burn, J.H., Dale, H.H.: The action of certain quaternary ammonium bases. J. Pharmacol. exp. Ther. 6, 417–438 (1914).
Buzas, A., Regnier, G.: Aminoalcoyl-1-réserpines. C.R. Acad. Sci. (Paris) 250, 1340–1342 (1960).
Carstens, E.: Blutdrucksenkende Pharmaka. Pharmazie 27, 675–682 (1972).
Cassinelli, C.M.: Therapeutic applications of the hypotensive action of Na-nitroprusside. Chem. Abstr. 52, 2283 (1958).
Caujolle, F., Chanh, P.H., Lecointe, P.: Pharmacology of the nitrosopentocyano ferrate of cobalt. Arch. int. Pharmacodyn. 172, 487–495 (1968).
Cavalleri, B., Bellasio, E., Sardi, A.: Synthesis of 6-trifluoromethyl-l, 4-dihydrazinophthalazine. J. med. Chem. 13, 148–149 (1970).
Caviness, V.S., Umphlet, T.L., Peasley, E.D., Bell, T.A., Sattersfield, G.H.: Potassium rhodanide treatment of hypertension. N. C. med. J. 2, 283–288 (1941).
Chopra, R.N., Chakravarti, M.: A preliminary note on the pharmacology of the alkaloids of R. serpentina. Indian J. Med. Res. 29, 763–768 (1941).
Christensen, H.D., Haley, T.J.: Comparison of the effect of phentolamine and SU 12.080 on femoral blood flow in the anesthetized cat. Arch. int. Pharmacodyn. 164, 84–90 (1966).
Chrusciel, M.: Chronic toxicity of carbethoxyphthalazino hydrazine and its influence on the excretion of 5-hydroxyindoleacetic acid and the activity of 5-HTP-decarboxylase in white rats. Brit. J. Pharmacol. 32, 104–112 (1968).
Clerk, A., Paris, R., Sterne, J.: Action of octyl alcohol on the arterial pressure and surface tension of the blood of an animal. Compt. rend. soc. biol. 111, 774–776 (1932). Federal Register 37, No. 97, p. 10.015 (1972).
Comer, W.T., Gomoll, A.W.: In: Burger, A. (Ed.): Medicinal Chemistry, p. 1046. (3rd Ed. New York-London-Sidney-Toronto: Wiley Interscience 1970.
Cosnier, D., Duchene-Marullaz, P., Grimal, J., Rispat, G., Streichenberger, G.: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazolin enitrate (Tolonidine) I: Action on blood pressure and heart rate. Arzneimittel-Forsch. 25, 1557–1561 (1975a).
Cosnier, D., Hache, J., Labrid, C., Streichenberger, G.: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline nitrate, III: Action on the secretions of the digestive tract and on the central nervous system, acute toxicity. Arzneimittel-Forsch. 25, 1926–1933 (1975c).
Cosnier, D., Labrid, C., Rispat, G., Streichenberger, G.: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline nitrate (Tolonidine), a new antihypertensive agent, II: Action on cardiac contraction, circulatory parameters and diuresis. Arzneimittel-Forsch. 25, 1802–1806 (1975b).
Cummings, J.R., Welter, A.N., Grace, J.L., Lipchuck, L.M.: Cardiovascular actions of guancydine in normotensive and hypertensive animals. J. Pharmacol. exp. Ther. 161, 88–97 (1968).
Curwain, B.P., Fake, C.S., Gordon, J.L., Mehta, M.D., Miller, D., Poyser, R.H., Watts, E.A.: Synthesis and antihypertensive properties of some N-(guanidinoalkyl)pyrrolidines. J. med. Chem. 14, 737–742 (1971).
Dannenfeldt, K.H.: Leonard Rauwolf (a biography), 321pp. Cambridge Mass.: Harvard University Press 1968.
Delbarre, B., Schmitt, H.: Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Europ. J. Pharmacol. 13, 356–363 (1975).
de Stevens, G., Wilhelm, M.: Antihypertensive agents. In: Jucker, E. (Ed.): Progress in Drug Research, Vol. 20, pp. 197–259. Basel-Stuttgart: Birkhäuser 1976.
Doebel, K.J., Francis, J.E.: 1, 2, 8, 9-Tetraazaphenalenes. Chem. Abstr. 70, 106.567a (1969).
Druey, J.: Pyridazines in the synthesis of drugs. Angew. Chem. 70, 5–13 (1958).
Druey, J., Marxer, A.: Hypotensive hydrazinophthalazines and related compounds. J. med. Chem. 1, 1–21 (1959).
Druey, J., Ringier, B.H.: Hydrazine derivatives of phthalazines and pyridazines. Helv. chim. Acta 34, 195–210 (1951).
Druey, J., Tripod, J.: Hydralazines. In: SchLIttler, E. (Ed.): Antihypertensive Agents, pp. 223–262. New York-London: Academic Press 1967.
Duchesne, E.A.: Répertoire des plantes utiles et des plantes vénéneuses du globe, p. 35. Paris 1836.
Ehrhart, G., Ruschig, H.: Arzneimittel, 2.te Aufl., Vol. 2, p. 150, 1972. Weinheim, Germany: Verlag Chemie
Ehrreich, S.J., Heringslake, J.E., Warren, F.R., Weinstock, J., Tedeschi, R.E.: Pharmacological effects of an unusual hypotensive agent (SKF 11.197). Effects on the cardiovascular system. Arch. int. Pharmacodyn. 179, 284–302 (1969).
Ernest, I., Jilek, J.O., Vejdelek,Z.J., Protiva, M.: Über einige neue (-)-Methylreserpatester. Coll. Czech. Chem. Commun. 24, 266–273 (1964).
Ernest, J., Protiva, M.: (±)Methyl-O-(O-carbethoxysyringoyl)-10-methoxydeserpidate. Coll. Czech. Chem. Commun. 26, 1137–1144 (1961).
Ernest, I., Protiva, M.: Synthese des racem. 12-Methylmercaptodeserpidins. Coll. Czech. Chem. Commun. 28, 3106–3112 (1963).
Everett,A.J., Lowe, L.A., Wilkinson, S.: Revision of the structures of (+)-tubocurarine chloride and (+)-chondrocurine. Chem. Commun. 1970, 1020–1021.
Fielden, R., Green, A.L.: A comparative study of the noradrenaline-depleting and sympathetic blocking actions of guanethidine and (-)-β-hydroxyphenethylguanidine. Brit. J. Pharmacol. 30, 155–165 (1967).
Fielden, R., Green, A.L.: Optical isomers of β-hydroxyphenethylguanidine: Effects on heart noradrenaline and sympathetic blockade. Brit. J. Pharmacol. 32, 350–359 (1968).
Fielden, R., Green, A.L., Willey, G.L.: Adrenergic neurone blocking activity of some aralkylguanidines. Brit. J. Pharmacol. 24, 395–407 (1965).
Fourneau, E., Bovet, D.: Recherches sur l’action sympatholytique d’un nouveau dérivé du dioxane. Arch. int. Pharmacodyn. 46, 178–191 (1933a).
Fourneau, E., Bovet, D.: Sympatholytic action of a new derivative of dioxan. Compt. rend. soc. biol. 113, 388–390 (1933b).
Fourneau, E., Maderni, P., De Lestrange, Y.: Heterocyclic bases derived from coumarans and benzodioxan. J. Pharmacol. Chim. 18, 185–191 (1933).
Freis, E.D.: Hypertension: A controllable disease. Clin. Pharmacol. Ther. 13, 627–632 (1972).
Freyburger, W.A., Weeks, J.R., Ducharme, D.W.: Cardiovascular actions of the hypotensive agent N, N-diallylmelamine (U 7720) Arch. exp. Path. Pharm. 251, 39–47 (1965).
Gadekar, S.M., Nibi, S., Cohen, E.: Hypotensive activity of some cyanoguanidines. J. med. Chem. 11, 811–814 (1968).
Gifford, R.W.: Hypotensive Drugs. In: Modell, W. (Ed.): Drugs of Choice 1970–1971. St. Louis, Mo.: C. V. Mosby.
Giudicelli, R., Beauvallet, M., Chabrier, P., Najer, H.: Sur l’action vasculaire de quelques amino-2-oxazolines. C. R. Acad. Sci. (Paris) 247, 891, 2494–2497 (1959).
GiudicellI, R., Najer, H., Lefèvre, F.: Relations between structure and activity in the N-(β-guanidinoethyl)azaspiroalkane series. C. R. Acad. Sci. (Paris) 260, 2944–2947 (1965).
Giudicelli, R., Najer, H., Sarret, M., Prouteau, M.: The pharmacologic activity in the N(β-guanidinoethyl)azaspiroalkane series. C. R. Acad. Sci. (Paris) 259, 1596–1598 (1964).
Giudicelli, R., Schmitt, H.: Propriétés antihypertensives et mécanisme d’action de la (diméthyl-2, 6-phenylamino)-2-oxazoline-1, 3. J. Pharmacol. 1, 339–358 (1970).
Goldring, W., Chasis, H.: Thiocyanate therapy in hypertension I: Observations on its tyxic effects. Arch, intern. Med. 49, 321–329 (1932).
Graubner, W., Wolf, M.: Kritische Betrachtungen zum Wirkungsmechanismus des 2-(2, 6-dichlorophenylamino)-2-imidazolinhydrochlorids. Arzneimittel-Forsch. 16, 1055–1058 (1966).
Greshoff, M.: Übersicht der alkaloidhaltigen Apocynaceen in Niederländ. Indien. Chem. Ber. 23, 3543 (1890).
Groot, S. de , Strating, J.: Reserpine analogs I. Rec. Trav. chim. Pays-Bas 80, 121–133 (1961).
Gross, F., Druey, J., Meier, R.: A new group of antihypertensive substances with a special mode of action. Experientia (Basel) 6, 19–21 (1950).
Gupta, J.C., Ghosh, S., Dutta, A.T., Kahali, B.S.: A note on the hypnotic principle of R. serpentina. J. Amer. pharm. Ass. 36, 416 (1947).
Gupta, J.C., Kahali, B.S., Dutt, A.: The hypnotic effect of a resin fraction isolated from the root of R. serpentina Benth., obtained from Dehra-Dun. Indian J. med. Res. 32, 183–188 (1944).
Gutman, J.: Modern Drug Encyclopedia and Therapeutic Guide, 1941, 138–139.
Hammer, J., Ulrych, M., Freis, E.: Hemodynamic and therapeutic effects of guancydine in hypertension. Clin. Pharmacol. Ther. 12, 78–90 (1971).
Hansson, L., Pascual, A., Julius, S.: Comparison of guanadrel and guanethidine. Clin. Pharmacol. Ther. 14, 204–208 (1973).
Hartmann, M., Isler, H.: Chemische Konstitution und pharmakologische Wirksamkeit von in 2-Stellung substituierten Imidazolinen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 192, 141–154 (1939).
Heise, A., Kroneberg, G., Schlossmann, K.: α-Sympathomimetische Eigenschaften als Ursache der blutdrucksteigernden und blutdrucksenkenden Wirkung von BAY 1470 (2-(2-, 6-xylidino)-5, 6-dihydro-4H-1,3-thiazinhydrochlorid). Naunyn-Schmiedebergs Axch. Pharmak. 268, 348–360 (1971).
Helgen, L., Stoutland, O., Agre, C.L.: Pyrolysis of N-phenylthiocarbamyl ethylenediamine and related materials. J. Org. Chem. 24, 884–886 (1959).
HermannHermann: Arch. f. Physiol. 39, 419 (1886); Thesis, Univ. Königsberg 1887, p. 34.
Hershenson, F.M., Rozek,L.F.: Synthesis and antihypertensive activity of 2-arylamino-l-azacycloalkenes. J. med. Chem. 14, 907–909 (1971).
Hess, H.J., Cronin, T.H., Scriabine, A.: Antihypertensive 2-Amino-4(3H)-quinazolinones. J. med. Chem. 11, 130–136 (1968).
Hidaka, H., Hara, F., Hashizume, V., Yano, M.: Selective inhibition of dopamine β-hydroxylase in the peripheral tissues by 5-dimethyldithio-carbamylpicolinic acid, its effect on stress-induced ulcer, ethanol-induced sleep and blood pressure. J. Pharmacol. exp. Ther. 191, 384–392 (1974).
Hidaka, H., Nagatsu, T., Takeya, K., Takeuchi, T., Suda, H., Kojiri, K., Matsuzaki, M., Umezawa, H.: Fusaric acid, a new hypotensive agent produced by fungi. J. Antibiot. (Tokyo) 22, 228–230 (1969); Chem. Abstr. 71, 29.127y (1969).
Hidaka, H., Takeya, K.: Blood pressure decreased by halobutylpicolinic acid, an inhibitory of dopamine β-hydroxylase Nature (Lond.) 239, 334–335 (1972).
Hieber, W., Nast, R., Proeschel, E.: Inorganic compounds of nitric oxide VI: The nitrosylcyano nickel complex. Z. anorg. Chem. 256, 145–158 (1948).
Hill, H.E.: A contribution to the toxicity of sodium nitroprusside, the decomposition and determination of sodium nitroprusside. Aust. J. chem. Inst. 9, 82–93 (1942).
Hoefke, W., Kobinger, W., Walland, A.: Relationship between activity and structure in the derivatives of Clonidine: Arzneimittel-Forsch. 25, 786–793 (1975).
Hoffmeister, W., Krueck, F.: Mechanism of action of potassium rhodanide as explanation for the blood pressure lowering effect in hypertension. Klin. Wschr. 32, 106–110 (1954).
Hofmann, A.: Die Mutterkornalkaloide. Encke, Stuttgart 1964.
Houlihan, W. J., Manning, R.E.: Secondary aminopyridazines as central nervous stimulants and as antihypertensives. Chem. Abstr. 75, 49.118g (1971).
Houlihan, W.J., Manning, R. E.: Pharmacologically active tertiary aminopyridazine derivatives. Chem. Abstr. 77, 152.207a (1972).
Huebner, C.F.: Rauwolfia Alkaloids XIII: Derivatives of reserpine. J. Amer. chem. Soc. 76, 5792 (1954).
Hueni, A.: Verfahren zur Herstellung eines neuen Imidazolins. A.P. 2.868.802. Chem. Abstr. 53, 10.253 (1959).
Ishii, Y., Fujii, Y., Mimura, C., Umezawa, H.: Pharmacological action of FD-008, a new dopamine β-hydroxylase inhibitor. Arzneimittel-Forsch. 25, 55–59 (1975).
Ishii, Y., Homma, M., Yoshikawa, A., Umezawa, H.: Pharmacological action of FD-008, a new dopamine -hydroxylase inhibitor. Arzneimittel-Forsch. 25, 181–185 (1975); see also Ishii, Y., Fujii, Y., Umezawa, H.: Jap. J. Pharmacol. 23, Suppl., 53, Abstr. 76 (1973).
Itallie, L. van, Steenhauer, A.J.: R. serpentina Benth. Arch. Pharm. 270, 313–322 (1932).
Jeger, O., Prelog, V.: Steroid alkaloids: Veratrum group. In: Manske, R.H.F. (Ed.): The Alkaloids, Vol. VII, pp. 363–417. New York-London: Academic Press 1960.
Jirkovsky, I., Protiva, M.: Synthese des racem. 10, 11-ethylendioxydespyrrolodeserpidins. Coll. Czech. Chem. Commun. 28, 2577–2581 (1962).
Johnson, C.C.: The actions and toxicity of sodium nitroprusside. Arch. int. Pharmacodyn. 35, 480–496 (1929).
Jones, P.H., Somani, P., Antihypertensive. U.S. Pat. 3840663 (3/23/1973 and 10/8/1974).
Jung, F., Petsch, G.: On the hypotensive activity of pentacyano ferrates, especially sodium nitroprusside. Acta biol. med. Germ. 19, 781–783 (1967).
Kahn, M.M., Ahmad, N.: Nitroprusside complexes of divalent cobalt, nickel, cadmium, zinc, copper, mangan, iron and trivalent titanium. Z. Anorgan. Allgem. Chem. 354, 301–306 (1967). Chem. Abstr. 68, 16598 (1968).
Keeler, R. F.: Teratogenic compounds of V. californicum VII: The structure of the glycosidic alkaloid cycloposine. Steroids 13, 579–588 (1969).
Keeler, R.F.: Teratogenic compounds of V. californicum XI: Gestational chronology and compound specifity in rabbits. Proc. Soc. exp. Biol. (N. Y.) 136, 1174–1179 (1971a).
Keeler, R.F.: Teratogenic compounds of V. californicum XIII: Structure of muldamine. Steroids 18, 741–752 (1971b).
Keeler, R.F.: Teratogenic compounds of V. californicum XIV: Limb deformations produced by cyclopamine. Proc. Soc. exp. Biol. (N. Y.) 142, 1287–1291 (1973).
Keeler, R.F., Binns, W.: Possible teratogenic effects of veratramine. Proc. Soc. exp. Biol. (N. Y.) 123, 921–923 (1966).
Keeler, R.F., Binns, W.: Teratogenic compounds from V. californicum III: Malformations of veratramine-induced type from ingestio nof plant or roots. Proc. Soc. exp. Biol. (N. Y.) 126, 452–454 (1967).
Kersting, F.: Klinische Prüfung, Phase I: Arzneimittel-Forsch. 23, 1657–1659 (1973).
King, H., Lourie, E. M., Yorke, W.: New trypanocidal substances. Lancet 1937 II, 1360–1363.
Korduba, C.A., Veals, J., Wohl, A., Symchowicz, S., Tabachnick, I.I.A.: Sch. 10.595, an effective dopamine β-hydroxylase inhibitor and a new hypotensive agent. Pharmacologist 13, 192, abstr. 010 (1971); J. Pharmacol. exp. Ther. 184, 671–677 (1973).
Kralt, T., Asma, W.J., Moed, H.D.: Reserpine analogues III: Alkoxy-β-phenylethylamine derivatives. Rec. Trav. chim Pays-Bas 80, 431–445 (1961).
Kreye, V.A.W., Bechtel, H., Hoebel, M.: Studies on sodium nitroprusside II: Structure-Activity-Relationships (in press).
Kroneberg, G., Oberdorf, A., Hoffmeister, F., Wirth, W.: Zur Pharmakologie von BAY 1470, eines Hemmstoffs adrenergischer und cholinergischer Neurone. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 256, 257–280 (1967).
Kroneberg, G., Schlossmann, K., Stoepel, K.: Pharmacology of N-(2-guanidinoethyl)-4-methyl-l, 2, 3, 6-tetrahydropyridine, a new antihypertensive agent. Arzneimittel-Forsch. 17, 199–207 (1967).
Kubikowski, P., Majcherczyk, J., Szymanska, J.: New hydrazinophthalazine derivatives of hypotensive activity. Acta physiol. pol. 16, 289–296 (1965); Chem. Abstr. 64, 5638 (1966).
Kupchan, S.M.: Hypotensive veratrum ester alkaloids. J. pharm. Sci. 50, 273–287 (1961).
Kupchan, S.M., By, A.W.: The chemistry of the veratrum group. In: Manske, R.H.F. (Ed.): The Alkaloids, Vol. X, pp. 193–285. New York-London: Academic Press 1968.
Kupchan, S.M., Flacke, W.E.: Hypotensive veratrum alkaloids. In: Schlittler, E. (Ed.): Antihypertensive Agents, pp. 429–458. New York-London: Academic Press 1967.
Lamb, I. D., White, A. C.: Some amidines and amidoximes with trypanocidal activity. J. chem. Soc. 1939, 1253–1257.
Lape, H.E., Fort, D., Frering, R., Skulan, T.: Antihypertensive activity of a dihydroiso-quinoline carboxamidoxime. Pharmacologist 13, 191 (1971).
Lape, H.E., Hoppe, J.O., Bell, M.R., Wood, D., Selberis, W.H., Arnold, A.: The antihypertensive properties of a series of indole and azaindole amidoximes with particular reference to 7-azaindole-3-acetamidoxime and indole-1-acetamidoxime. Arch. int. Pharmacodyn. 171, 394–414 (1968).
Laverty,R.: A comparison of the behavioural effects of some hypotensive imidazoline derivatives. Europ. J. Pharmacol. 9, 163–169 (1969).
Lee, G.E.: Non-quaternary blockers. In: Schlittler, E. (Ed.): Antihypertensive Agents, pp. 295–329. New York-London: Academic Press 1967.
Lee, G. E., Wragg, W. R., Corne, S. J., Edge, N. D., Reading, H. W.: 1:2:2:6:6-Pentamethylpiperidine, a new hypotensive agent. Nature (Lond.) 181, 1717–1719 (1958).
Leonard, N.J., Hauck, F.P.: Unsaturated amines X: The mercuric acetate route to substituted piperidines, Δ 2-tetrahydropyridines and Δ 2-tetrahydroanabasines. J. Amer. chem. Soc. 79, 5279–5292 (1957).
Leonard, N.J., Nommensen, E.W.: Studies on the mechanism of the von Braun reaction. J. Amer. chem. Soc. 71, 2808–2813 (1949).
Leroy, B. R.: The thiocyanates in solution, the natural physiological solvent of the body. N. Y. med. J. 1909, 802–805.
LeVine, P. B., Gearien, J.E.: Stereospecific synthesis of a reserpine analog. J. Organ. Chem. 26, 4060–4062 (1961).
Libermann, D., Rouaix, A.: Hydrazine derivatives of some heterocyclic compounds. Bull. Soc. chim. Fr. 1959, 1793–1798.
Lindner, E., Kaiser, J.: Tiamenidine (Hoechst 440), a new antihypertensive substance. Arch. int. Pharmacodyn. 211, 305–325 (1974).
Lofgren, N., Erdtman, H.: A new group of compounds acting as local anesthetics. Svensk Kern. Tid. 49, 163–174 (1937).
Lucas, R. A., Kiesel, R. J., Ceglowski, M.J.: Rauwolfia Alkaloids XXXII: Further studies on the synthesis and activity of reserpine analogs. J. Amer. chem. Soc. 82, 493–495 (1960).
Lucas, R.A., Kuehne, M.E., Ceglowski, M.J., Dziemian, R.L., McPhillamy, H.B.: Rauwolfia Alkaloids XXXI: The synthesis and activity of some reserpine analogs. J. Amer. chem. Soc. 81, 1928–1932 (1959).
Mahaffey,L.W.: Toxicity of sodium nitroprusside for guinea pigs. Aust. J. chem. Inst. 9, 93–94 (1942).
Major, R.H.: Possible relationship between guanidine and high blood pressure. Amer. J. med. Sci. 170, 228–232 (1925).
Major, R.H., Stephenson, W.: The effects of methylguanidines. Bull. Johns Hopk. Hosp. 35, 140–141 (1924).
Manchot, W., Düsing, J.: Studies of the similarity of ruthenium to iron: Sodium nitrosopenta cyano ruthenite. Z. anorg. Chem. 212, 109–112 (1933).
Marxer, A., Schier, O.: Quaternary ganglionic blockers. In: Schlittler, E. (Ed.): Antihypertensive Agents, pp. 279–294. New York-London: Academic Press 1967.
Massie, E., Etheridge, C.B., O’Hare, J.P.: Thiocyanate therapy in vascular hypertension. New Engl. J. Med. 219, 736–740 (1938).
Matier, W.L., Comer, W.T., Deitchman, D.: Sulfamoyl azides: Hydrolysis rate and hypotensive activity. J. med. Chem. 15, 538–541 (1972); see also Chem. Abstr. 75, 150.893f (1971).
Maxwell, R.A., Plummer, A.J., Daniel, A.I., Schneider, F., Povalski, H.: Concerning the mechanisms of the cardiovascular actions of hexahydro-1-azepine propionamidoxime. J. Pharmacol. exp. Ther. 124, 127–134 (1958b).
Maxwell, R.A., Mull, R.P., Plummer, A. J.: (2-(Octahydro-l-azocinyl)-ethyl)guanidine sulfate (SU 5864), a new synthetic antihypertensive agent. Experientia (Basel) 15, 267 (1959).
Maxwell, R.A., Ross, S.D., Plummer, A.J.: Pharmacology of hexahydro-1-azepine propionamidoxime (SU 4029). J. Pharmacol. exp. Ther. 123, 128–139 (1958a).
Maxwell, R.A., Schneider, F.L.: Some actions of hexahydro-1-azepine propionamidoxime HCl (SU 4029) in certain autonomic pathways. J. Pharmacol. exp. Ther. 134, 347–355 (1961).
Mazumdar, D.C., Mukherji, K.L.: Rauwolfia in hypertension. J. Indian med. Ass. 19, 362–367 (1950).
McPhillamy, H.B., Huebner, C.F., SchLIttler, E., St. Andre, A.F., Ulshafer, P.R.: Rauwolfia Alkaloids XIX: The constitution of deserpidine and reserpine. J. Amer. chem. Soc. 77, 4335–4343 (1955).
Mull, R.P.: Belgian Patent 611653 (1962). Aminoguanidines. Chem. Abstr. 57, 16414 (1962).
Mull, R.P., Egbert, M.E., Dapero, M.R.: Guanidines with antihypertensive activity I. J. Org. Chem. 25, 1953–1956 (1960).
Mull, R.P., Maxwell, R.A.: Guanethidine and related adrenergic neurone blocking agents. In: Schlittler, E. (Ed.): Antihypertensive Agents, p. 131. New York-London: Academic Press 1967.
Mull, R.P., Maxwell, R.A., Plummer, A.J.: Antihypertensive activity of hexahydro-1-azepine propionamidoxime. Nature (Lond.) 180, 1200–1201 (1957).
Mull, R.P., Mizzoni, R.H., Dapero, M.R., Egbert, M.E.: Guanidines with antihypertensive activity II. J. med. Chem. 5, 944–949 (1962).
Muller, J.M., Schlittler, E., Bein, H.J.: Reserpin, der sedative Wirkstoff aus R. serpentina Benth. Experientia (Basel) 8, 338 (1952).
Muller, G., Allais, A.: Sur quelques analogues synthétiques de la réserpine et de la déserpidine. Naturwissenschaften 47, 82 (1960).
Monro, A.M., Potter, G.W.H., Sewell, M. J.: Adrenergic neurone blocking agents II: Some dioxane-substituted derivatives of guanoxan. J. med. Chem. 10, 880–883 (1967).
Nador, K.: Benzylguanidines. Hungarian Pat. 155717 (Gedeon Richter) Chem. Abstr. 70, 114811r (1969).
Nagatsu, I., Mitsutami, K., Umezawa, H., Matsuzaki, M., Takeuchi, T.: Adrenal tyrosine hydroxylase and dopamine β -hydroxylase in spontaneous hypertensive rats. Nature (Lond.) 230, 381–382 (1971).
Najer, H., Chabrier, P., Giudicelli, R.: Sur quelques amino-2-oxazolines N-substituées douées d’activité vasculaire. Bull. Soc. chim. Fr. 1959, 352–359.
Najer, H., Giudicelli, R.: Sur quelques amino-2-oxazolines N-substituées douées d’activité vasculaire (2° mémoire). Bull. Soc. chim. Fr. 1960, 1650–1652.
Najer, H., Giudicelli, R., Loiseau, J., Menin, J.: Le (triméthoxy-3″-4″-5″-benzoate de β-hydroxyéthyl)-3′-pipéridino-N-ethyl)-3-méthoxy-6-indole. Bull. Soc. chim. Fr. 1963, 2831–2840.
Najer, H., Giudicelli, R., Sette, J.: Une nouvelle synthèse des arylamino-2-imidazolines. Bull. Soc. chim. Fr. 1961, 2114–2126.
Najer, H., Giudicelli, R., Sette, J.: Guanidines with antihypertensive activity IV: N-(β-guanidinoethyl)azaspiroalkanes. Bull. Soc. chim. Fr. 1964, 2572–2581.
Najer, H., Giudicelli, R., Sette, J., Menin, J.: Guanidines with antihypertensive activity V: N-(β-guanidinoethyl)azaspiroalkanes. Bull. Soc. chim. Fr. 1965, 204–208.
Nakamura, T., Yasuda, H., Obayashi, A., Tanabe, O., Matsumura, S., Ueda, F., Ohata, K.: Antihypertensive and fungal dopamine β-hydroxylase inhibitor. J. Antibiot. (Tokyo) 28, 477 (1975). Chem. Abstr. 83, 75.176J (1975).
Nogradi, T.: Untersuchungen über Rauwolfia-Alkaloid-Modelle I: Tryptamin- und Graminderivate. Mh. Chem. 88, 768–777 (1957a).
Nogradi, T.: Untersuchung über Rauwolfia-Alkaloid-Modelle II: 2-substituierte Indole, Tetrahydrocarbolin- und Hexahydroyohimbanderivate. Mh. Chem. 88, 1087–1094 (1957b).
Norton, S., Phillips, A.P.: A new type of autonomic blocking agent. Nature (Lond.) 172, 867 (1953).
Ozawa, H., Gomi, Y., Otsuki, L: Pharmacological studies of guanethidine dervatives III: Yakugaku Zasshi 85, 112–119 (1965); Chem. Abstr. 62, 15314 (1965).
Ozawa, H., Sato,S.: The adrenergic neurone blocking action of 2-(methylphenylamino)ethyl-guanidine sulfate: Chem. Pharm. Bull. (Tokyo) 14, 1291–1297 (1966); 15, 840–844 (1967).
Paco, G. Di, Tauro, C.S.: On some new esters and amides of 3, 4, 5-trimethoxy benzoic acid with potential reserpine activity. Farmaco, Ed. sci. 13, 64–74 (1958).
Page, I.H.: The nature of treatment of hypertension. Trans. Amer. ther. Soc. 48, 56–70 (1947).
Page, I.H.: Humoral and vasomotor controls of blood vessels. Bull. N. Y. Acad. Med. 28, 131–144 (1952).
Page, I. H.: Drug treatment in hypertension. A public lecture given at the Symposium on antihypertensive therapy, principles and practice (Gross, F. Ed.), pp. 602–614. Berlin-Heidelberg-New York: Springer 1966.
Page, I.H., Corcoran, A., Dustan, P.H., Koppany, T.: Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients. Circulation 11, 188–198 (1955).
Parsons, D.G., Turner, A.F., Murray, B.G.: Substituted 1-aminophthalazines. Chem. Abstr. 70, 57872k (1969); see also (Vantorex Ltd.) New substituted phthalazines. Chem. Abstr. 68, 49632a (1968).
Paton, W. D. M., Zaimis, E. J.: The pharmacological actions of the polymethylene bistrimethylammonium salts. Nature (Lond.) 161, 718–719 (1948); Brit. J. Pharmacol. 4, 381–400 (1949).
Pauli, W.: Zur Kenntnis der Rhodantherapie. Zbl. ges. Ther. 22, 19 (1904).
Peterfalvi, M., Jequier, R.: La 10-méthoxy déserpidine: étude pharmacologique. Arch. int. Pharmacodyn. 124, 237–254 (1960).
Pezzangaro, F.: Treatment of arterial hypertension by intravenous injection of octyl alcohol. C. R. Soc. Biol. (Paris) 119, 1331–1333 (1935).
Pham-Huu-Chanh, Lecointe, P., Donnat, L.: Pharmacology of barium nitrosyl pentacyano ferrate. Arzneimittel-Forsch. 19, 1836–1842 (1969).
Plattner, P.A., Keller, W., Boller, A.: Welkstoffe und Antibiotika. Konstitution und Synthese der Fusarinsäure. Synthese von 5-Äthyl- und 5-n-Hexylpyridin-2-carbonsäure. Helv. chim. Acta 37, 1379–1392 (1954).
Plummer, A. J., Schneider, J. A., Barrett, W. E.: A series of tris (dialkylaminoalkyl) amines with ganglionic blocking activity. Arch. int. Pharmacodyn. 97, 1–12 (1954).
Popelak, A., Lettenbauer, G.: Über die Verätherung der Yohimbanalkaloide mit Diazomethan. Arch. Pharm. 295, 427–430 (1962).
Protiva, M., Jilek, J.O., Hach, V., Adlerova, E., Michajlyszyn, V.: Einfache Reserpin-modelle mit dem Cyclohexanring E. Coll. Czech. Chem. Commun. 24, 83–92 (1959a).
Protiva, M., Vejdelek, Z. J., Jilek, J. O., Macek, K.: Einige weitere Derivate des Tryptamins und 1, 2, 3, 4-Tetrahydronorharmans. Coll. Czech. Chem. Commun. 24, 3978–3987 (1959b).
Pruss, T.P., Hidalgo, J.: Cardiovascular profile of the antihypertensive agent guanadrel. Proc. Soc. exp. Ther. 139, 600–603 (1972).
Raffa, L., Monzani, A., Di Bella, M.: 1, 2, 4-Benzothiadiazine derivatives XVIII: The chlorination of 3-oxodihydrobenzo-l, 2-thiadiazine-l,l-dioxide. Farmaco, Ed. sci. 17, 234–243 (1962); Chem. Abstr. 58, 3435 (1963).
Racine, M.: A propos des traitements récents de l’hypertension artérielle. J. Prat. (Paris) 49, 753–756 (1935).
Rieppel, F.W.: Leonhard Rauwolf. Ein Beitrag zu seiner Biographie. Dtsch. med. Wschr. 80, 653–655 (1955).
Rieppel, F.W.: Zur Frühgeschichte der Rauwolfia. Sudhoffs Arch. Gesch. Med. 40, 231–239 (1956).
Robertson, J.E.: Biguanides French Patent 1.320.255 (1963); Chem. Abstr. 59, 10.010 (1963).
Robison, M.M., Lucas, R.A., McPhillamy, H.B., Barrett, W., Plummer, A.J.: Rauwolfia Alkaloids XXXV: Potent, fast acting sedatives from methylreserpate. Experientia (Basel) 17, 14 (1961a).
Robison, M.M., Lucas, R.A., McPhillamy, H.B., Dziemian, R.L., Hsu, I., Kiesel, R.J.: Rauwolfia Alkaloids XXXVI: Non-hypotensive sedatives derived from methylreserpate. J. Amer. chem. Soc. 83, 2694–2700 (1965b).
Rodriguez, R., Hong, E., Vidrio, H., Pardo, E.G.: Pharmacology of a group of phenyl-piperazine tetrazole derivatives with adrenergic blocking actions. J. Pharmacol. exp. Ther. 148, 54–65 (1965).
Roth, F.E., Schurr, J., Moutis, E., Govier, W.M.: Comparative hypotensive effect and toxicity of sodium azide and selected organic azides. Arch. int. Pharmacodyn. 108, 473–480 (1956).
Rubin, A.A., Roth, F.E., Winbury, M.M.: A non-diuretic benzothiadiazine with antihypertensive properties. Nature (Lond.) 192, 176–177 (1961).
Rubin, A.A., Roth, F.E., Winbury, M.M., Topliss, J.G., Sherlock, M.H., Sperber, N., Black, J.: A new class of antihypertensive agents. Science 133, 2067 (1961).
Russel, W.O., Stahl, W.C.: Fatal poisoning from potassium rhodanide treatment of hypertension. J. Amer. med. Ass. 119, 1177–1181 (1942).
Sah, H.J., Sah, P.P.T., Peoples, S.A.: The new antihypertensive agent guanethidine: a review. Discovery and development, chemical structure, physical properties, and pharmacological actions. Arzneimittel-Forsch. 16, 53–58 (1966).
Sandoz: Belg. Pat. 737.553 (U.S. priority 8/16 and 26/1968).
Saunders, J.P., Himwich, W. A.: Properties of the transsulfurase responsible for conversion of cyanide to thiocyanate. Amer. J. Physiol. 163, 404–409 (1950).
Schier, O., Marxer, A.: Antihypertensive agents 1962–1968. In: Jucker, E. (Ed.): Progress in Drug Research, Vol. 13, pp. 101–135/Basel-Stuttgart: Birkhäuser 1969.
Schlittler, E.: Rauwolfia alkaloids with special reference to the chemistry of reserpine. In: Manske, R.H.F. (Ed.): The Alkaloids, Vol. 8, pp. 287–334. New York: Academic Press 1965.
Schlittler, E., Druey, J., Marxer, A.: Antihypertensive agents. In: Jucker, E. (Ed.): Progress in Drug Research, Vol. 4, pp. 295–351. Basel-Stuttgart: Birkhäuser 1962.
Schoepke, H.G., Brondyk, H.D., Wiemeler, L.H., Schmidt, J.L.: Cardiovascular pharmacology of tertiary octylguanidine (B.P. 1184). Arch. int. Pharmacodyn. 153, 185–204 (1965).
Schuemann, H. J., Werner, U.: Hemmung der Hormonfreisetzung aus dem Nebennierenmark durch BAY 6781, eine antihypertensive Substanz. Naunyn-Schmiedebergs Arch. Pharmak. 268, 71–82 (1971).
Scriabine, A., Booher, K.D., Pereira, J.N., McShane, W.K., Constantine, J.W., Koch, R.C., Miknius, S.: Pharmacological studies with guanisoquin. J. Pharmacol. exp. Ther. 147, 277–287 (1965).
Scriabine, A., Booher, K.D., Pereira, J.N., McShane, W.K., Koch, R.C.: Some pharmacological actions of N,N′-dimethyl-l, 2, 3, 4-tetrahydroisoquinoline-2-carboxamidine HCl (P-4746). Arch. int. Pharmacodyn. 164, 435–443 (1966).
Semonsky, M., Zikan, V., Votova, Z., Podvalova, L, Ponec, K.: N(D-6-Methyl-8-isoergolenyl)-N, N-diethylurea acid maleate (LYSENYL-Spofa, a new antiserotonine drug). Čs. Farm. 17, 296–305 (1968). C. A. 70, 1976e (1969).
Sen, G., Bose, K.C.: Rauwolfia serpentina: A new Indian drug for insanity and high blood pressure. Indian med. World 2, 194–201 (1931).
Sherman, G. P.: Bradycardia effects of the antihypertensive agent 2, 6-dichlorobenzylidene aminoguanidine acetate (WY 8678) in the dog. Pharmacologist 13, 192 (abstr. 005) (1971).
Short,J.H., Darby, T.D.: Sympathetic nervous system blocking agents III: Derivatives of benzylguanidines. J. med. Chem. 10, 833–840 (1967).
Short, J.H., Ours, C.W., Ranus, W.J.: Sympathetic nervous system blocking agents V: Derivatives of isobutyl-, tert. butyl-, and neopentyl-guanidine. J. med. Chem. 11, 1129–1135 (1968).
Siddiqui, S.: A note on the alkaloids of R. serpentina Benth. J. Indian chem. Soc. 16, 421–422 (1939).
Siddiqui, S., Siddiqui, R.H.: Chemical examination of the roots of R. serpentina Benth. J. Indian. chem. Soc. 8, 667–680 (1931).
Siddiqui, S., Siddiqui, R. H.: Alkaloids of Rauwolfia serpentina Benth. Part. I. J. Indian chem. Soc. 9, 539–544 (1932).
Siddiqui, S., Siddiqui, R. H.: The alkaloids of R. serpentina Benth. Part II: Studies in the ajmaline series. J. Indian chem. Soc. 12, 37–47 (1935).
Sivach, T.A., Kapitonenko, T. A.: Hypotensive properties of 3-azidocyclohexanone semicarbazone. Chem. Abstr. 83, 71780d (1975).
Sonn, A.: Imidazolines. U.S. Pat. 2.161.938 (Chem. Abstr. 33, 7316 (1939).
Spivakova, R.P.: Pharmacological properties of a number of sympatholytics, derivatives of guanidine. Farmakol. i Toksikol 34, 650–653 (1971). [Chem. Abstr. 76, 108017u (1972)].
Spinks, A., Young, E. H. P.: Polyalkylpiperidines: A new series of ganglionic blocking agents. Nature (Lond.) 181, 1397–1398 (1958).
Stieglitz, E. J.: Bismuth subnitrate in the therapy of hypertension. J. Pharmacol. exp. Ther. 32, 23–35 (1928).
Stieglitz, E. J.: Therapeutic results with bismuth subnitrate in hypertensive arterial disease. J. Pharmacol. exp. Ther. 46, 343–356 (1932).
Stoll, A., Hofmann, A.: Die Alkaloide der Ergotoxingruppe: Ergocristin, Ergokryptin und Ergocornin. Helv. chim. Acta 26, 1570–1601 (1943).
Stoll, A., Hofmann, A.: The ergot alkaloids. In: Manske, R.H.F. (Ed.). The Alkaloids, Chemistry and Physiology, Vol. VIII, pp. 725–783. New York-London: Academic Press 1965.
Stoll, A., Hofmann, A.: The chemistry of the ergot alkaloids. In: Pelletier, S.W. (Ed.): Chemistry of the Alkaloids, pp. 267–300. New York: Van Nostrand Reinhold 1970.
Suda, H., Takeuchi, T., Nagatsu, T., Matsuzaki, U., Matsumoto, L, Umezawa, H.: Inhibition of dopamine β-hydroxylase by 5-alkylpicolinic acids and their hypotensive effects. Chem. pharm. Bull. 17, 2377–2380 (1969).
Symchowicz, S., Staub, M.: Disposition of Sch. 10595 in animals and man. J. Pharmacol. exp. Ther. 191, 324–330 (1974).
Tamari, K., Kaji, J.: The mechanism of the growth inhibiting action of fusarinic acid on plants: Chem. Abstr. 48, 8330 (1954).
Terasawa, F., Kameyama, M.: Clinical trial of a new hypotensive agent, fusaric acid (5-butylpicolinic acid). Chem. Abstr. 79, 27527 (1973).
Topliss, J.G., Konzelman, L.M., Shapiro, E.P., Sperber, N., Roth, F.E.: Antihypertensive agents II: 3 Substituted 2H 1, 2, 4 benzothiadiazine-l, l dioxides. J. med. Chem.7, 269–273 (1964).
Topliss, J.G., Sherlock, M.H., Reimann, H., Konzelman, L.M., Shapiro, E.P., Pettersen, B.W., Schneider, H., Sperber, N.: Antihypertensive agents I: Non diuretic 2H-1, 2, 4-benzothiadiazine-l,l-dioxides. J. med. Chem. 6, 122–127 (1963).
Topliss, J. G., Yudis, M.D.: Correlation of antihypertensive activity with structure in a series of 2H-1, 2, 4 benzothiadiazine-1,1-dioxides using the substituent constant approach. J. med. Chem. 15, 394–400, 400–403 (1972).
Trcka, V., Dlabac, A., Vanecek, M.: Mediodespidine, hypotensive reserpoid without sedative effect I: Comparison of sedative and hypotensive activity in monkeys. Life Sci. 4, 2257–2261 (1956a).
Trcka, V., Carlsson, A.: Part II: Effect on monoamine levels in mouse organs. Life Sci. 4, 2263–2267 (1965b).
Turner, F.A., Gearien, J.E.: Synthesis of reserpine analogs. J. org. Chem. 24, 1952–1955 (1959).
Ueno, K., Ishikawa, F., Miyazaki, S.: Pyrido (3–4d) pyridazine derivatives. Chem. Abstr. 75, 140874–140876 (1971).
Ueno, K., Miyazaki, S., Akashi, A.: Hypotensive l-(alkylidenehydrazino)-phthalazines. Chem. Abstr. 77, 5504s (1972).
Umezawa, H., Takeuchi, T., Miyano, K., Hamano, H., Tanaka, W.: Antihypertensive 5(ω-haloalkyl)picolinic acids. Ger. Offen. 2305758 (Chem. Abstr. 79, 115.444w (1973).
Urech, E., Marxer, A., Miescher, K.: 2-Aminoalkyl-imidazoline. Helv. chim. Acta 33, 1386–1407 (1950).
Vakil, R.J.: A clinical trial of R. serpentina in essential hypertension. Brit. Heart J. 11, 350–355 (1949).
Vazakas, A. J., Doluisio, J.T.: Synthesis and pharmacology of some basic esters of 3, 4, 5-trimethoxybenzoic acid. J. pharm. Sci. 53, 165–169 (1964).
Vedernikov, Y.P.: Effects of Redergam on vascular responses to sciatic nerve stimuli. (Russ.). Chem. Abstr. 61, 12505 (1964).
Vedernikov, Y.P.: Pharmacology of Redergam and assays of its analgesic activity in animal and clinical tests. Farmakol. i Toksikol. 26, 431–434 (1963) (Russ.). Chem. Abstr. 60, 2234 (1964).
Vejdelek, Z.D., Trcka, V., Protiva, M.: Chemistry of 1, 2, 3, 4-Tetrahydronorharman-l-carboxylic acid and derivatives. J. Med. Pharm. Chem. 3, 427–440 (1961).
Velasco, M., Gilbert, C.A., Rutledge, C.O., McNay, J.L.: Bupicomide: Clin. Pharmacol. Ther. 18, 145–153 (1975).
Velasco, M., McNay, J.L.: Clin. Pharmacol. Ther. 15, 222 (1974).
Velluz, L.: Réserpines de synthèse. Ann. pharm. franç. 17, 15–25 (1959); Prod, pharm. 14, 607–609 (1959).
Velluz, L., Muller, G., Allais, A.: 6-Alcoyl réserpines. C. R. Acad. Sci. (Paris) 247, 1746–1748 (1958b).
Velluz, L., Mullee, G., Allais, A.: Deserpidine derivatives. French pat. 1.180.514 (1959); Chem. Abstr. 55, 9450 (1961).
Velluz, L., Peterfalvi, M., Jequier, R.: Un clivage des effects réserpiques. C. R. Acad. Sci. (Paris) 247, 1905–1907 (1958a).
Votava, Z., Podvalova,L., Vojtechovsky, M.: Unterschiede in der pharmakologischen Wirkung von halluzinogenen und nicht halluzinogenen Lysergsäurederivaten (LSD-25, Deseryl, Lysenyl und Mesenyl). Arzneimittel-Forsch. 16, 220–222 (1966).
Warawa, E.J.: Synthesis of 3-alkyl-2, 6-dicyanopyridines by a unique rearrangement. Preparation of fusaric acid analogs. J. org. Chem. 40, 2092–2095 (1975).
Wenner, W.: 1, 2, 3, 4-Tetrahydroisoquinoline derivatives with antihypertensive properties. J. med. Chem. 8, 125–126 (1965).
Werle, E., Fried, R.: Zur Kenntnis der biologischen Wirkung organischer Azide. Biochem. Z. 322, 507–512 (1952).
Werle, E., Fried, R.: Über das Azid-entgiftende Ferment tierischer Gewebe. Biochem. Z. 321, 500–507 (1951).
Werle, E., Fried, R.: Monoamidoxydase und Azidabbau durch tierische Gewebe. Biochem. Z. 323, 14–20 (1952).
Werle, E., Mennicken, G.: Über die Inaktivierung von Tryptamin und Tyramin durch tierische Gewebe. Biochem. Z. 296, 99–104 (1938).
Werle, E., Stücker, F.: Zur Pharmakologie der Azide. Arzneimittel-Forsch. 8, 28–31 (1958).
Werner, L.H., Barrett, W.E.: Adrenergic blocking agents. In: Schlittler, E. (Ed.): Antihypertensive Agents, pp. 331–392. New York-London: Academic Press 1967.
Westphal, K.: Über die Rhodantherapie des genuinen arteriellen Hochdrucks. Münch. med. Wschr. 73, 1187 (1926).
Westphal,K., Blum, R.: Die Rhodantherapie des genuinen arteriellen Hochdrucks und ihre Bedeutung. Dtsch. Arch. klin. Med. 152, 331–353 (1926).
Wilson, J., Vesey, C.J., Cole, P.V.: Nitroprusside revisited. Brit. med. J. 1971 IV, 116.
Wollweber, H., Wilms, H., Hiltmann, R., Stoepel, K., Kroneberg, G.: Guanidinoalkyl-azacycloalkanes: Chemical structure and antihypertensive activity. Arzneimittel-Forsch. 21, 2089–2100 (1971).
Woodward, R.B., Bader, F.E., Bickel, H., Frey, A.J., Kierstead, R. W.: The total synthesis of reserpine. J. Amer. chem. Soc. 78, 2023–2025, 2657 (1956); Tetrahedron 2, 1–57 (1958).
Wylie, D.W., Archer, S.: Structure-activity relationships of l-[(3-indolyl)-alkyl]-4-aryl piperazines, a new series of tranquilizers. J. med. Pharm. Chem. 5, 932–943 (1962).
Yabuta, T., Kambe, K., Hayashi, T.: Fusarinic acid, a new product of the bakanae fungus. Chem. Abstr. 29, 1132 (1935).
Zikan, V., Semonsky, M.: Mutterkornalkaloide, Mitt. 31: Ein Beitrag zur Herstellung von N(D-6-Methyl-8-isoergolenyl)N, N′-diäthylharnstoff. Pharmazie 23, 147–148 (1968).
Zins, G.R.: The in vivo production of a potent, long-acting hypotensive metabolite from diallylmelamine. J. Pharmacol. exp. Ther. 150, 109–117 (1965).
Zins, G.R., Emmert, D.E., Walk, R.A.: Hypotensive metabolite production and sequential metabolism of N, N-diallylmelamine in rats, dogs, and man. J. Pharmacol. exp. Ther. 159, 194–205 (1968).
Zwieten, P. A. van: A new antihypertensive compound, 44–549. Pharmacology 13, 352 (1975).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Schlittler, E. (1977). The Chemistry of Antihypertensive Agents. In: Gross, F. (eds) Antihypertensive Agents. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66309-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-66309-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66311-6
Online ISBN: 978-3-642-66309-3
eBook Packages: Springer Book Archive